Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSND.L Regulatory News (SND)

  • There is currently no data for SND

PDMR Dealing

9 Aug 2019 16:05

RNS Number : 6185I
Sanderson Group PLC
09 August 2019
 

FOR IMMEDIATE RELEASE

9 August 2019

 

 

SANDERSON GROUP PLC

 

PDMR Dealing

 

Sanderson Group plc ('Sanderson' or 'the Group'), the specialist provider of digital technology solutions, innovative software and managed services for the retail, wholesale, supply chain logistics, food and drink processing and manufacturing market sectors, announces that Mrs Angela Winn, wife of Christopher Winn, Chairman, transferred 7,000,000 ordinary Shares of 10 pence each in the Group ('Ordinary Shares') into Christopher Winn's name for nil consideration.

 

Following the transfer, their combined beneficial interest remains unchanged at 8,000,000 Ordinary Shares, representing 13.23 per cent. of the Group's issued share capital.

 

Enquiries

 

Sanderson Group plc

0333 123 1400

Christopher Winn, Chairman

 

Ian Newcombe, Chief Executive

 

Richard Mogg, Finance Director

 

 

 

Singer N+1 - Nominated Advisor and Broker

020 7496 3000

Mark Taylor

James White

 

 

 

Walbrook PRPaul Vann

0117 985 8989

or 07768 807631

 

 

 

Director Shareholding

 

1

Details of PDMR/Person Closely Associated with them ('PCA')

(a)

Name

Angela Winn

(b)

Position / status

PCA of Christopher Winn, Chairman

(c)

Initial notification / amendment

Initial notification

2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument

Ordinary shares of 10p each

 

Legal Entity Identifier

213800I78F2ZHZH2T148

(b)

Nature of the transaction

Disposal

(c)

Price(s) andvolume(s)

Price(s)

Volume(s)

 

Nil

[7,000,000]

 

 

(d)

Aggregated information

Aggregated volume Price

N/A - Single transaction

 

(e)

Date of the transaction

8 August 2019

 

(f)

Place of the transaction

London Stock Exchange

 

 

 

 

 

 

 

 

 

 

 

1

Details of PDMR/Person Closely Associated with them (PCA)

(a)

Name

Christopher Winn

(b)

Position / status

Chairman

(c)

Initial notification / amendment

Initial notification

2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument

Ordinary shares of 10p each

 

Legal Entity Identifier

213800I78F2ZHZH2T148

(b)

Nature of the transaction

Purchase

(c)

Price(s) andvolume(s)

Price(s)

Volume(s)

 

Nil

7,000,000

 

 

(d)

Aggregated information

Aggregated volume Price

N/A - Single transaction

 

(e)

Date of the transaction

8 August 2019

 

(f)

Place of the transaction

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKCDKPBKDBFK
Date   Source Headline
21st Aug 20247:00 amRNSCancellation - Sondrel (Holdings) plc
12th Aug 20241:54 pmRNSResult of GM, Cancellation and Re-registration
22nd Jul 20247:00 amRNSProposed cancellation of Admission, Notice of GM
18th Jul 20248:09 amRNSFinal Results and Posting of Annual Report-Replace
18th Jul 20247:30 amRNSRestoration - Sondrel (Holdings) plc
18th Jul 20247:01 amRNSChief Financial Officer Succession
18th Jul 20247:00 amRNSFinal Results and Posting of Annual Report
16th Jul 20247:00 amRNSNotice of Results
1st Jul 20247:30 amRNSSuspension - Sondrel (Holdings) plc
27th Jun 20245:32 pmRNSResult of AGM
24th Jun 20244:26 pmRNSSuspension of Trading on AIM
18th Jun 20247:00 amRNSDirectorate Changes
12th Jun 202412:45 pmRNSUpdate re Subscription and Loan Conversion
10th Jun 202410:40 amRNSReceipt of NSIA Approval
30th May 20241:52 pmRNSResult of General Meeting
29th May 20246:07 pmRNSNotice of AGM
29th May 20247:00 amRNSRegulatory Condition to Conditional Subscription
22nd May 20247:00 amRNSChief Executive Officer Succession
14th May 20247:00 amRNSSubscription and Posting of Circular
29th Apr 20242:35 pmRNSPDMR Dealing
29th Apr 20247:00 amRNSSuccessful Milestone Completion
22nd Apr 20244:45 pmRNSPDMR Dealings
10th Apr 20245:26 pmRNSNotification of Major Holdings
2nd Apr 20249:39 amRNSNotification of Major Holdings
28th Mar 20241:08 pmRNSFurther CLN and Amended Exclusivity Agreement
27th Mar 20244:55 pmRNSUpdated Supply Arrangements
25th Mar 20243:46 pmRNSResult of General Meeting
25th Mar 20247:00 amRNSFurther re Material ASIC contract
11th Mar 20247:00 amRNSPosting of Circular and Notice of General Meeting
6th Mar 20247:00 amRNSConvertible Loan Note and Exclusivity Agreement
1st Mar 20247:00 amRNSFurther re Corporate Update
27th Feb 202412:52 pmRNSReplacement: Notification of Major Holdings
27th Feb 20248:33 amRNSNotification of Major Holdings
27th Feb 20247:00 amRNSNew Contract Win and Corporate Update
8th Feb 20248:42 amRNSStatement re Share Price Movement
5th Feb 20247:00 amRNSCorporate Update
10th Jan 20247:00 amRNSFY23 Update
5th Jan 20247:00 amRNSBoard Change
28th Dec 20232:52 pmRNSTrading Update
1st Dec 20233:31 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSResult of placing of shares in Sondrel (Holdings)
23rd Nov 20237:00 amRNSChange of Nominated Adviser and Broker
13th Nov 20237:00 amRNSProduction Order
20th Oct 20237:00 amRNSFounding member of Arm Total Design ecosystem
27th Sep 202312:01 pmRNSNotification of Major Holdings
27th Sep 202311:57 amRNSNotification of Major Holdings
21st Sep 20237:00 amRNSDelivery of prototypes for three ASIC projects
21st Sep 20237:00 amRNSResults for the half year ended 30 June 2023
20th Sep 20231:09 pmRNSBoard Update
18th Sep 20237:00 amRNSSenior Management Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.